NITRD requests information on AI research, development plan

The Networking and Information Technology Research and Development (NITRD) Program is seeking information on the National Artificial Intelligence (AI) Research and Development Strategic Plan.

The program filed a request for information on the AI research plan in an effort to decide if it should be revised and improved. The request was published on Wednesday, Sept. 26.

According to the request, the AI research and development plan was developed in 2016 as a way to guide government efforts in AI research and development and listed seven strategic aims. The NITRD program is a multiagency source of federally funded work on advanced information technologies (IT).

"Through this (RFI), NITRD seeks input from the public, including those directly performing (AI) research and development and directly affected by such R&D, on whether the strategic plan should be revised and, if so, the ways in which it may be improved," the request states.

"This includes suggestions as to the addition, removal, or modification of strategic aims, comments as to existing strategic aims as well as their past or future implementation by the Federal government."

Responses to the request can be submitted through Oct. 26.

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup